Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
Comparison Results
Keymed Biosciences, Inc.
HK$62.80
HK$15.58B
-54.25
74.25%
4 Buy
0 Hold
0 Sell
Strong Buy
Simcere Pharmaceutical Group Limited
HK$13.11
HK$34.03B
33.96
97.44%
3 Buy
0 Hold
0 Sell
Strong Buy
Lepu Biopharma Co. Ltd. Class H
HK$5.43
HK$10.09B
-48.22
82.21%
1 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$15.00
HK$8.67B
-15.09
78.15%
0 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.16
HK$11.18B
78.16
234.44%
―
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
55.50
23.65
74.25%
HK:1672
Ascletis Pharma, Inc.
13.00
9.85
312.70%
HK:2096
Simcere Pharmaceutical Group Limited
13.11
6.58
100.77%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.43
2.78
104.91%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.00
6.48
76.06%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
28.16
19.69
232.47%